Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis-Reference-Cited by-同舟云学术

Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

Published:2023-08 Issue:5 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Broos Jelle Y.¹,Loonstra Floor C.¹,de Ruiter Lodewijk R.J.¹,Gouda Mariam¹,Fung Wing Hee¹,Schoonheim Menno M.¹^ORCID,Heijink Marieke¹,Strijbis Eva M.M.¹,Teunissen Charlotte¹^ORCID,Killestein Joep¹,de Vries Helga E.¹,Giera Martin¹^ORCID,Uitdehaag Bernard M.J.¹,Kooij Gijs¹^ORCID

Affiliation:

1. From the MS Center Amsterdam (J.Y.B., W.H.F., H.E.d.V., G.K.), Molecular Cell Biology and Immunology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc; Leiden University Medical Centre (LUMC) (J.Y.B., M.H., M.A.G.), Center of Proteomics and Metabolomics; MS Center Amsterdam (F.C.L., L.R.J.d.R., W.H.F., E.M.M.S., J.K., B.M.J.U.), Neurology, Vrije Universiteit Amsterdam, MS Center Amsterdam (M.M.T.E.E.G., C.T.), Neurochemistry Laboratory, Department of Clinical...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207459

Reference37 articles.

1. Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation

2. Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases

3. Palumbo S. Pathogenesis and progression of multiple sclerosis: the role of arachidonic acid-mediated neuroinflammation. In: Zagon IS, McLaughlin PJ, editors. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. Codon Publications; 2017.

4. Review: Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis

5. Pro-resolving lipid mediators are leads for resolution physiology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocrelizumab alters the circulating metabolome in people with relapsing–remitting multiple sclerosis;Annals of Clinical and Translational Neurology;2024-08-26

2. Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis;Neurology;2024-07-09

3. Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity;iScience;2024-03

4. Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?;Journal of Neuroinflammation;2024-01-17

5. A Birth Year Cohort and What It Can Reveal About Lipid Mediators as Putative Biomarkers of Progression in Multiple Sclerosis;Neurology;2023-08